LOCAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE TREATMENT OF TONSILLOPHARYNGITIS

Download full text PDF
Issue: 
2
Year: 
2015

Professor A. Kiselev (1), MD; I. Dronov (2), Candidate of Medical Sciences 1 -Novosibirsk State Medical University 2 -I.M. Sechenov First Moscow State Medical University

Sore throat caused by tonsillopharyngitis in the vast majority of cases is a very frequent reason people visit their doctor. Symptomatic therapy aimed mainly at relieving pain plays a large role in the treatment of tonsillopharyngitis. The local nonsteroidal ant-inflammatory drug flurbiprofen has the high efficacy and safety established in evidence-based clinical trials.
Keywords: 
sore throat
tonsillopharyngitis
nonsteroidal ant-inflammatory drugs
flurbiprofen

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Linder J., Bates D., Lee G. et al. Antibiotic treatment of children with sore throat // JAMA. – 2005; 294 (18): 2315–22.
  2. Linder J., Stafford R. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989–1999 // JAMA. – 2001; 286 (10): 1181–6.
  3. Worrall G. Acute sore throat // Can. Fam. Physician. – 2007; 53 (11): 1961–2.3.
  4. Piñeiro-Pérez R., Hijano-Bandera F., Alvez-González F. et al. Consensus document on the diagnosis and treatment of acute tonsillopharyngitis // An. Pediatr. Barc. – 2011; 75 (5): 1–13.
  5. Printsipy etiopatogeneticheskoj terapija ostryh faringitov: Metodicheskie rekomendatsii. Sostavitel': S.V. Rjazantsev / SPb, 2013; 32 s.
  6. Kozlov S.N., Strachunskij L.S., Rachina S.A. Farmakoterapija ostrogo tonzillofaringita v ambulatornoj praktike: rezul'taty mnogotsentrovogo farmakoepidemiologicheskogo issledovanija // Ter. arh. – 2004; 76 (5): 45–51.
  7. Portier H., Grappin M., Chavanet P. New strategies for angina case management in France // Bull. Acad. Natl. Med. – 2003; 187 (6): 1107–16.
  8. Andreeva I.V. Farmakoepidemiologija antibakterial'nyh preparatov u naselenija. Avtoref. dis. ... kand. med. nauk. Smolensk, 2003; 21 s.
  9. Shpynev K.V., Krechikov V.A.. Sovremennye podhody k diagnostike streptokokkovogo faringita // Klin. mikrobiol. antimikrob. himioter. – 2007; 9 (1): 20–33.
  10. Otvagin I.V., Sokolov N.S. Sovremennye aspekty diagnostiki infetsij, vyzvannyh streptokokkami gruppy A // Klin. mikrobiol. antimikrob. himioter. – 2011; 13 (3): 223–30.
  11. Maltezou H., Tsagris V., Antoniadou A. et al. Evaluation of a rapid antigen detection test in the diagnosis of streptococcal pharyngitis in children and its impact on antibiotic prescription //J. Antimicrob. Chemother. – 2008; 62 (6): 1407–12.
  12. Ayanruoh S., Waseem M., Quee F. et al. Impact of rapid streptococcal test on antibiotic use in a pediatric emergency department // Pediatr. Emerg. Care. – 2009; 25 (11): 748–50.
  13. Dronov I., Botneva A., Neskorodova K. et al. The experience of rapid diagnosis of streptococcal tonsillopharyngitis in children in outpatient care. 24th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, 10–13 May 2014, poster R342.
  14. Klinicheskaja farmakologija po Gudmanu i Gilmanu / M.: Praktika, 2006; 1648 s.
  15. Abdel-Aziz A., Al-Badr A., Hafez G. Flurbiprofen // Profiles Drug Subst. 15. Excip. Relat. Methodol. – 2012; 37: 113–81.
  16. Chalmers I., Cathcart B., Kumar E. et al. Clinico-pharmacological studies and clinical evaluation of flurbiprofen. A new non-steroidal antirheumatic agent // Ann. Rheum. Dis. – 1972; 31 (4): 319–24.
  17. URL: http://www.ncbi.nlm.nih.gov/pubmed (obraschenie 12.01.2015).
  18. Kim S., Chang Y., Cho H. et al. Non-steroidal anti-inflammatory drugs for the common cold // Cochrane Database Syst. Rev. – 2013; 6: CD006362.
  19. Schachtel B., Aspley S., Shephard A. et al. Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study // Trials. – 2014; 3 (15): 263.
  20. Schachtel B., Homan H., Gibb I. et al. Demonstration of dose response of flurbiprofen lozenges with the sore throat pain model // Clin. Pharmacol. Ther. – 2002; 71 (5): 375–80.
  21. Watson N., Nimmo W., Christian J. et al. Relief of sore throat with the ant inflammatory throat lozenge flurbiprofen 8.75 mg: a randomised, double-blind, placebo-controlled study of efficacy and safety // Int. J. Clin. Pract. – 2000; 54 (8): 490–6.
  22. Benrimoj S., Langford J., Christian J. et al. Efficacy and tolerability of the anti-inflammatory throat lozenge flurbiprofen 8.75mg in the treatment of sore throat // Clin. Drug Investigation. – 2001; 21 (3): 183–93.
  23. Sedinkin A.A., Balandin A.V., Dimova A.D. Rezul'taty otkrytogo prospektivnogo kontroliruemogo randomizirovannogo sravnitel'nogo issledo-vanija effektivnosti i perenosimosti tabletok dlja rassasyvanija flurbi-profen (strepfen) i paratsetamola u bol'nyh s bol'ju v gorle pri ostryh infektsionno-vospalitel'nyh zabolevanijah verhnih dyhatel'nyh putej // Vestnik otorinolaringol. – 2004; 5: 52–4.
  24. Russo M., Bloch M., de Looze F. et al. Flurbiprofen microgranules for relief of sore throat: a randomised, double-blind trial // Br. J. Gen. Pract. – 2013; 63: 149–55.
  25. Blagden M., Christian J., Miller K. et al. Multidose flurbiprofen 8.75 mg lozenges in the treatment of sore throat: a randomised, double-blind, placebo-controlled study in UK general practice centres // Int. J. Clin. Pract. – 2002; 56 (2): 95–100.
  26. Schachtel B., Aspley S., Shephard A. et al. Onset of action of a lozenge containing flurbiprofen 8.75 mg: a randomized, double-blind, placebo-controlled trial with a new method for measuring onset of analgesic activity // Pain – 2014; 155 (2): 422–8.
  27. Shephard A., Smith G., Aspley S. et al. Randomised, double-blind, placebo- controlled studies on flurbiprofen 8.75 mg lozenges in patients with/without group A or C streptococcal throat infection, with an assessment of clinicians' prediction of «strep throat» // Int. J. Clin. Pract. – 2014; Epub. Ahead of print.